Observational study on rare gynecologic tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is watching and collecting data from patients with rare gynecologic tumors. It uses special tests on your tumor samples to learn more about these cancers, which may help find better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rare type of gynecologic cancer, such as clear cell carcinoma, small cell carcinoma, carcinosarcoma, sarcoma, cervical gastric adenocarcinoma, ovarian germ cell tumor, ovarian sex cord stromal tumor, trophoblastic tumor, or PECOMA.
- You have already had surgery to remove the tumor and received the pathology results.
- You are willing to participate, follow the study rules, and sign a consent form.
- You agree to let researchers collect and use your data and tumor samples for genetic and other tests.
- You do not have any other cancers elsewhere in your body.
- You do not have any uncontrolled neurological or psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is collecting tissue and blood samples from people with rare gynecological cancers, such as unusual ovarian tumors, uterine sarcomas, or vulvar cancer. The goal is to use advanced lab tests (called multi-omics) to learn more about these cancers and improve treatment.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study looks at metastatic ovarian cancer by analyzing many types of patient data (from “multi-omics,” which means different kinds of lab and biological information). It may help doctors better understand the disease and improve future care.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study tests a new approach called SmartMatch that looks at the unique traits of your tumor to find the best treatment for you. The goal is to see if this personalized approach is feasible and helpful for people with rare gynecologic cancers.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Rare Gynecological Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.